Surface vaccine combo
نویسندگان
چکیده
منابع مشابه
The 2012 syphilis & HIV combo
We report a case of a homosexual male patient with an unusual presentation of syphilis and HIV co-infection. The initial skin problem on the scalp appeared banal and seborrhoeic. However, this soon became multifocal and general symptoms developed as well. The patient's personal history signalled the possibilities of sexually transmitted diseases. Subsequent investigations unfolded a modern derm...
متن کاملThe LDV-COMBO system for SMT
We describe the LDV-COMBO system presented at the Shared Task. Our approach explores the possibility of working with alignments at different levels of abstraction using different degrees of linguistic analysis from the lexical to the shallow syntactic level. Translation models are built on top of combinations of these alignments. We present results for the Spanish-to-English and English-toSpani...
متن کاملInfluenza A surface glycosylation and vaccine design.
We have shown that glycosylation of influenza A virus (IAV) hemagglutinin (HA), especially at position N-27, is crucial for HA folding and virus survival. However, it is not known whether the glycosylation of HA and the other two major IAV surface glycoproteins, neuraminidase (NA) and M2 ion channel, is essential for the replication of IAV. Here, we show that glycosylation of HA at N-142 modula...
متن کاملResponse to hepatocarcinoma Hca-F of mice immunized with heat shock protein 70 from elemene combo tumor cell vaccine.
To analyze immune response to murine hepatocarcinoma Hca-F of mice immunized with heat shock protein 70 (HSP70) derived from elemene combo tumor cell vaccine (EC-TCV) of Hca-F, HSP70 was isolated from EC-TCV by ADP affinity chromatography. Mice were immunized with HSP70 intraperitoneally three times and spleen cells were sampled. For cells, their proliferation and cytotoxicity against Hca-F wer...
متن کاملDrug combo beneficial in colorectal cancer.
The BRAF V600E mutation, well documented in melanoma, is also present in approximately 8% of patients with colorectal cancer. However, whereas BRAF inhibitors like vemurafenib (Zelboraf; Genentech) are highly effective for the treatment of melanoma, their benefi t as monotherapy in BRAF-mutant colorectal cancer is limited at best. “This type of metastatic colorectal cancer has a very poor progn...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nature Biotechnology
سال: 2000
ISSN: 1087-0156
DOI: 10.1038/76384